Skip to main content

Day: October 25, 2019

United Bankers Corporation: Acquisition of Own Shares 25.10.2019

25.10.2019 at 18:30UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 25.10.2019The shares held by United Bankers Corporation on 25.10.2019:On behalf of United Bankers CorporationAntti Salakka         Mikko VirtanenFor more information, please contact:Patrick Anderson, toimitusjohtaja, United Bankers OyjSähköposti: patrick.anderson@unitedbankers.fiPuhelin: 0400 244 544,09 25 380 236www.unitedbankers.fiAttachmentUB SBB 25102019

Continue reading

UNITED BANKERS OYJ:n OMIEN OSAKKEIDEN HANKINTA 25.10.2019

25.10.2019 klo 18:30UNITED BANKERS OYJ:n OMIEN OSAKKEIDEN HANKINTA 25.10.2019Yhtiön hallussa olevat omat osakkeet 25.10.2019:United Bankers Oyj:n puolestaAntti Salakka         Mikko VirtanenLisätietoja antaa:Patrick Anderson, toimitusjohtaja, United Bankers OyjSähköposti: patrick.anderson@unitedbankers.fiPuhelin: 0400 244 544,09 25 380 236www.unitedbankers.fiLiiteUB SBB 25102019

Continue reading

Merus Announces Presentation and Poster on MCLA-128 and MCLA-129 Programs at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

UTRECHT, The Netherlands and BOSTON, Oct. 25, 2019 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS) (“Merus”, “we”, “our” or the “Company”), a clinical-stage bispecific antibody company developing Biclonics®, innovative full-length human bispecific antibody therapeutics, today announced that data from its MCLA-128 and MCLA-129 programs will be presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics being held October 26-30, 2019 in Boston, Massachusetts. Presentation and Poster Details: MCLA-128PresentationTitle: Clinical proof-of-concept for MCLA-128, a bispecific HER2/3 antibody therapy, in NRG1 fusion-positive cancersAuthors:  Alison M Schram, Eileen M O’Reilly, Romel Somwar, Ryma Benayed, Sara Shameem, Thrusha Chauhan, Jean Torrisi, Jim Ford,David Maussang, Ernesto Wasserman, Marc...

Continue reading

Generex Announces Results of Annual Stockholders’ Meeting

MIRAMAR, Fla., Oct. 25, 2019 (GLOBE NEWSWIRE) — /(Business Wire)/– Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced the results of the annual meeting of the Company’s stockholders held on October 25, 2019. Brian McGee, Dr. James H. Anderson, Jr., MD, Dr. Craig Eagle, MD, and Larry Salvo were re-elected as independent members of the Company’s Board of Directors. Omar Gzouli and Mark Prioletti were elected as new independent Board Members, and Joseph Moscato, the Company’s President & Chief Executive Officer, and Andrew Ro, the Company’s Chief Investment Officer, were also re-elected to the Board.The proposal to ratify the appointment of Mazurs USA LLP as independent public accountants in respect of the Company’s fiscal year-end was approved by...

Continue reading

Marsh Appointed to Serve on National Community Bankers Council

EMLENTON, Pa., Oct. 25, 2019 (GLOBE NEWSWIRE) — William C. Marsh was recently appointed to serve on the American Bankers Association’s (ABA) Community Bankers Council for the 2019-2020 year.  Mr. Marsh is Chairman of the Board, President and Chief Executive Officer at The Farmers National Bank of Emlenton.The Community Bankers Council (CBC) identifies community bank priorities and represents community banking in the ABA’s policy-making process.  The ABA recognizes the CBC as the focal point for providing world class solutions, leadership and advocacy for the nation’s community banks.  The CBC consists of community bank presidents and CEOs from across the nation focusing on government relation issues, banking trends and competitive priorities. Council members actively participate at the state and local level to ensure Council messages...

Continue reading

Gazit Globe Offer to Acquire All Minority Shareholder Interests in Subsidiary Atrium Has Not Been Approved

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY RESTRICTED JURISDICTION OR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTIONTEL AVIV, Israel, Oct. 25, 2019 (GLOBE NEWSWIRE) — Gazit Globe (TASE: GZT), a leading global real estate company focused on the ownership, management and development of mixed use properties in urban markets, announced today that its offer to acquire the entire issued, and to be issued ordinary share capital of Atrium European Real Estate Limited (VSE/Euronext: ATRS) (“Atrium”) that is not already owned directly or indirectly by Gazit-Globe Ltd or its subsidiaries Gazit Gaia Limited and Gazit Midas Limited (“Gazit“) has not been approved by the majority of Atrium minority shareholders.On 23 July 2019, Atrium...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.